한글목차

세계 혈액성분채집 기기 시장 규모는 2024년 28억 달러에 달했습니다. 향후 IMARC Group은 시장이 2033년까지 57억 달러에 달할 것으로 예상하며, 2025년부터 2033년까지 7.63%의 연평균 성장률(CAGR)을 기록할 것으로 예측했습니다.

세포, 혈장, 혈소판, 백혈구 등 혈액에서 특정 성분을 제거하기 위해 원심분리 또는 막여과법을 사용하여 혈액에서 특정 성분을 제거하는 데 사용되는 혈액성분채집 기기. 남은 혈액 성분은 기증자나 환자의 혈류에 다시 주입됩니다. 혈액은행 및 다양한 병증 치료에 적용되고 있습니다. 최근에는 최신 혈액성분채집 기기의 도입으로 자동 용출, 유체역학 등 고도의 기능이 개발되어 혈소판과 적혈구(RBC)의 농축 채취가 가능해졌습니다.

신종 코로나바이러스 감염증(COVID-19)이 확산되고 효과적인 백신과 치료법이 없는 상황에서 회복기 혈장치료가 중증 환자 치료 대책으로 떠오르고 있습니다. 이 치료법에서는 완치된 환자로부터 회복기 혈장(CP)을 채취하여 항체원으로 활동 중인 환자에게 수혈하는 아페레시스 기기를 활용하고 있습니다. 이 외에도 만성질환 및 신경질환 유병률 증가, 헌혈자 수 증가도 시장 성장에 기여하고 있습니다. 또한, 유리한 상환 정책과 의료 인프라의 개선도 전 세계적으로 혈액성분채집 기기의 판매를 촉진하고 있습니다. 그 외에도 자동 인터페이스 시스템, 스크린 내비게이션, 그래픽 사용자 인터페이스 디스플레이를 갖춘 고급 변형의 도입, 연구 개발(R&D) 활동에 대한 투자 증가 등이 향후 몇 년 동안 시장 전망을 밝게 해줄 것으로 예상됩니다.

본 보고서에서 다루는 주요 질문

• 세계 혈액성분채집 기기 시장은 지금까지 어떻게 성장해왔고, 앞으로 어떻게 성장할 것인가?
• COVID-19가 전 세계 혈액성분채집 기기 시장에 미치는 영향은?
• 주요 지역 시장은?
• 제품별 시장 분석은?
• 용도별 시장 내역은?
• 시술별 시장 분석은?
• 기술별 시장 분석은?
• 최종사용자별 시장 분석은 어떻게 되는가?
• 산업 가치사슬의 다양한 단계는 무엇인가?
• 업계의 주요 촉진요인과 과제는 무엇인가?
• 세계 혈액성분채집 기기 시장의 구조와 주요 업체는?
• 업계 내 경쟁은 어느 정도인가?

목차

제1장 서문

제2장 조사 범위와 조사 방법

• 조사 목적
• 이해관계자
• 데이터 소스
  • 1차 정보
  • 2차 정보
• 시장 추정
  • 상향식 접근
  • 하향식 접근
• 조사 방법

제3장 주요 요약

제4장 소개

제5장 세계의 혈액성분채집 기기 시장

• 시장 개요
• 시장 실적
• COVID-19의 영향
• 시장 예측

제6장 시장 내역 : 제품별

• 일회용 혈액성분채집 키트
• 혈액성분채집 기기

제7장 시장 내역 : 용도별

• 채혈
• 치료
  • 주요 유형
    • 신경학
    • 혈액학
    • 신장질환
    • 기타

제8장 시장 내역 : 시술별

• 혈장 교환
• 혈소판 제거 요법
• 적혈구 제거 요법
• 백혈구 제거 요법
• 광선요법
• 기타

제9장 시장 내역 : 기술별

• 막 여과
• 원심분리

제10장 시장 내역 : 최종사용자별

• 혈액 채취 센터
• 병원과 진료소
• 기타

제11장 시장 내역 : 지역별

• 북미
  • 미국
  • 캐나다
• 아시아태평양
  • 중국
  • 일본
  • 인도
  • 한국
  • 호주
  • 인도네시아
  • 기타
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인
  • 러시아
  • 기타
• 라틴아메리카
  • 브라질
  • 멕시코
  • 기타
• 중동 및 아프리카

제12장 SWOT 분석

제13장 밸류체인 분석

제14장 Porter's Five Forces 분석

제15장 가격 분석

제16장 경쟁 구도

• 시장 구조
• 주요 기업
• 주요 기업 개요
  • Asahi Kasei Corporation
  • B. Braun Melsungen Aktiengesellschaft
  • Baxter International Inc.
  • Fresenius Kabi Aktiengesellschaft(Fresenius SE & Co. KGaA)
  • Haemonetics Corporation
  • Hemacare Corporation(Charles River Laboratories, Inc.)
  • Kaneka Corporation
  • Kawasumi Laboratories Inc.
  • Medica SpA
  • Nikkiso Co Ltd.
  • Terumo BCT Inc.(Terumo Corporation)

영문목차

The global apheresis equipment market size reached USD 2.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.7 Billion by 2033, exhibiting a growth rate (CAGR) of 7.63% during 2025-2033.

Apheresis equipment is used to remove specific constituents from the blood, such as the cells, plasma, platelets or leukocytes, using either centrifugal or membrane filtration methods. The remaining blood components are then reintroduced into the bloodstream of the donor or patient. It finds application in blood banks and the treatment of various medical conditions. In recent years, the introduction of modern apheresis equipment has led to the development of advanced features, such as auto elutriation and fluid flow dynamics, and has enabled the collection of platelets or red blood cells (RBCs) concentrates.

Due to the spread of the coronavirus disease (COVID-19) and lack of an effective vaccine or treatment, convalescent plasma therapy is emerging as a measure for treating critically ill patients. Apheresis equipment is utilized in this therapy to collect convalescent plasma (CP) from fully recovered patients and transfuse it to active patients as a source of antibodies. Besides this, the growing prevalence of chronic diseases and neurological disorders, along with the rising number of blood donors, is also contributing to the market growth. Moreover, favorable reimbursement policies, coupled with improving healthcare infrastructure, are also driving the sales of apheresis equipment around the world. Other factors, such as the introduction of advanced variants with automated interface systems, screen navigation and graphical user interface displays, along with the increasing investments in research and development (R&D) activities, are expected to create a positive outlook for the market in the coming years.

Key Market Segmentation:

Breakup by Product:

• Disposable Apheresis Kits
• Apheresis Machine

Breakup by Application:

• Blood Collection
• Treatment
  • Neurology
  • Hematology
  • Renal Diseases
  • Others

Breakup by Procedure:

• Plasmapherasis
• Plateletpherasis
• Erythrocytapheresis
• Leukapheresis
• Photopheresis
• Others

Breakup by Technology:

• Membrane Filtration
• Centrifugation

Breakup by End User:

• Blood Collection Centers
• Hospitals and Clinics
• Others

Breakup by Region:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Asahi Kasei Corporation, B. Braun Melsungen Aktiengesellschaft, Baxter International Inc., Fresenius Kabi Aktiengesellschaft (Fresenius SE & Co. KGaA), Haemonetics Corporation, Hemacare Corporation (Charles River Laboratories Inc.), Kaneka Corporation, Kawasumi Laboratories Inc., Medica SpA, Nikkiso Co Ltd. and Terumo BCT Inc. (Terumo Corporation).

Key Questions Answered in This Report:

• How has the global apheresis equipment market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global apheresis equipment market?
• What are the key regional markets?
• What is the breakup of the market based on the product?
• What is the breakup of the market based on the application?
• What is the breakup of the market based on the procedure?
• What is the breakup of the market based on the technology?
• What is the breakup of the market based on the end user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global apheresis equipment market and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Apheresis Equipment Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Disposable Apheresis Kits
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Apheresis Machine
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Application

• 7.1 Blood Collection
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Treatment
  • 7.2.1 Market Trends
  • 7.2.2 Major Types
    • 7.2.2.1 Neurology
    • 7.2.2.2 Hematology
    • 7.2.2.3 Renal Diseases
    • 7.2.2.4 Others
  • 7.2.3 Market Forecast

8 Market Breakup by Procedure

• 8.1 Plasmapherasis
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Plateletpherasis
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Erythrocytapheresis
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Leukapheresis
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Photopheresis
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast
• 8.6 Others
  • 8.6.1 Market Trends
  • 8.6.2 Market Forecast

9 Market Breakup by Technology

• 9.1 Membrane Filtration
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Centrifugation
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast

10 Market Breakup by End User

• 10.1 Blood Collection Centers
  • 10.1.1 Market Trends
  • 10.1.2 Market Forecast
• 10.2 Hospitals and Clinics
  • 10.2.1 Market Trends
  • 10.2.2 Market Forecast
• 10.3 Others
  • 10.3.1 Market Trends
  • 10.3.2 Market Forecast

11 Market Breakup by Region

• 11.1 North America
  • 11.1.1 United States
    • 11.1.1.1 Market Trends
    • 11.1.1.2 Market Forecast
  • 11.1.2 Canada
    • 11.1.2.1 Market Trends
    • 11.1.2.2 Market Forecast
• 11.2 Asia Pacific
  • 11.2.1 China
    • 11.2.1.1 Market Trends
    • 11.2.1.2 Market Forecast
  • 11.2.2 Japan
    • 11.2.2.1 Market Trends
    • 11.2.2.2 Market Forecast
  • 11.2.3 India
    • 11.2.3.1 Market Trends
    • 11.2.3.2 Market Forecast
  • 11.2.4 South Korea
    • 11.2.4.1 Market Trends
    • 11.2.4.2 Market Forecast
  • 11.2.5 Australia
    • 11.2.5.1 Market Trends
    • 11.2.5.2 Market Forecast
  • 11.2.6 Indonesia
    • 11.2.6.1 Market Trends
    • 11.2.6.2 Market Forecast
  • 11.2.7 Others
    • 11.2.7.1 Market Trends
    • 11.2.7.2 Market Forecast
• 11.3 Europe
  • 11.3.1 Germany
    • 11.3.1.1 Market Trends
    • 11.3.1.2 Market Forecast
  • 11.3.2 France
    • 11.3.2.1 Market Trends
    • 11.3.2.2 Market Forecast
  • 11.3.3 United Kingdom
    • 11.3.3.1 Market Trends
    • 11.3.3.2 Market Forecast
  • 11.3.4 Italy
    • 11.3.4.1 Market Trends
    • 11.3.4.2 Market Forecast
  • 11.3.5 Spain
    • 11.3.5.1 Market Trends
    • 11.3.5.2 Market Forecast
  • 11.3.6 Russia
    • 11.3.6.1 Market Trends
    • 11.3.6.2 Market Forecast
  • 11.3.7 Others
    • 11.3.7.1 Market Trends
    • 11.3.7.2 Market Forecast
• 11.4 Latin America
  • 11.4.1 Brazil
    • 11.4.1.1 Market Trends
    • 11.4.1.2 Market Forecast
  • 11.4.2 Mexico
    • 11.4.2.1 Market Trends
    • 11.4.2.2 Market Forecast
  • 11.4.3 Others
    • 11.4.3.1 Market Trends
    • 11.4.3.2 Market Forecast
• 11.5 Middle East and Africa
  • 11.5.1 Market Trends
  • 11.5.2 Market Breakup by Country
  • 11.5.3 Market Forecast

12 SWOT Analysis

• 12.1 Overview
• 12.2 Strengths
• 12.3 Weaknesses
• 12.4 Opportunities
• 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

• 14.1 Overview
• 14.2 Bargaining Power of Buyers
• 14.3 Bargaining Power of Suppliers
• 14.4 Degree of Competition
• 14.5 Threat of New Entrants
• 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

• 16.1 Market Structure
• 16.2 Key Players
• 16.3 Profiles of Key Players
  • 16.3.1 Asahi Kasei Corporation
    • 16.3.1.1 Company Overview
    • 16.3.1.2 Product Portfolio
    • 16.3.1.3 Financials
    • 16.3.1.4 SWOT Analysis
  • 16.3.2 B. Braun Melsungen Aktiengesellschaft
    • 16.3.2.1 Company Overview
    • 16.3.2.2 Product Portfolio
    • 16.3.2.3 SWOT Analysis
  • 16.3.3 Baxter International Inc.
    • 16.3.3.1 Company Overview
    • 16.3.3.2 Product Portfolio
    • 16.3.3.3 Financials
    • 16.3.3.4 SWOT Analysis
  • 16.3.4 Fresenius Kabi Aktiengesellschaft (Fresenius SE & Co. KGaA)
    • 16.3.4.1 Company Overview
    • 16.3.4.2 Product Portfolio
    • 16.3.4.3 SWOT Analysis
  • 16.3.5 Haemonetics Corporation
    • 16.3.5.1 Company Overview
    • 16.3.5.2 Product Portfolio
    • 16.3.5.3 Financials
    • 16.3.5.4 SWOT Analysis
  • 16.3.6 Hemacare Corporation (Charles River Laboratories, Inc.)
    • 16.3.6.1 Company Overview
    • 16.3.6.2 Product Portfolio
  • 16.3.7 Kaneka Corporation
    • 16.3.7.1 Company Overview
    • 16.3.7.2 Product Portfolio
    • 16.3.7.3 Financials
    • 16.3.7.4 SWOT Analysis
  • 16.3.8 Kawasumi Laboratories Inc.
    • 16.3.8.1 Company Overview
    • 16.3.8.2 Product Portfolio
    • 16.3.8.3 Financials
  • 16.3.9 Medica SpA
    • 16.3.9.1 Company Overview
    • 16.3.9.2 Product Portfolio
    • 16.3.9.3 Financials
  • 16.3.10 Nikkiso Co Ltd.
    • 16.3.10.1 Company Overview
    • 16.3.10.2 Product Portfolio
    • 16.3.10.3 Financials
    • 16.3.10.4 SWOT Analysis
  • 16.3.11 Terumo BCT Inc. (Terumo Corporation)
    • 16.3.11.1 Company Overview
    • 16.3.11.2 Product Portfolio
    • 16.3.11.3 SWOT Analysis